Translate Sign in JOIN

Mamel Quelapio, MD

User Photo

About Mamel Quelapio, MD
Program Manager/Executive Officer
Programmatic Management of Drug-resistant TB (PMDT)
Tropical Disease Foundation
Makati City, Philippines

Role(s) / Profession(s)

  • Manager (Site/Facility, Program, Project)

Organization

  • Tropical Disease Foundation
    Website: http://www.tdf.org.ph/ Type: Non-Governmental Organization Country: Philippines About: The Tropical Disease Foundation (TDF) is a private, non-stock, non-profit science foundation organized in 1984. Since then, it has become a leading institution in the implementation of research, service, and training projects in infectious diseases. The TDF has undertaken studies in pneumonia in children, Hepatitis B Virus infection, and antimicrobial resistance. In recent years, tuberculosis has become the main focus of research, service and training initiatives of the TDF. On behalf of the Department of Health, the 1997 nationwide tuberculosis prevalence survey was undertaken by the TDF. For this project, the TDF was awarded the Outstanding Health Research Award (OHRA) by the Department of Science and Technology.

Work Location(s)

  • Philippines

Mamel 's Communities

Language(s)

  • English

Recent Contributions

  • activity_icon

    Mamel Quelapio, MD started a discussion "Question about treatment outcome" in the MDR-TB Treatment & Prevention community.

    I am writing to ask a question regarding outcome. I'd like to cite this almost real scenario which is shared by a few patients in our cohort. A patient missed treatment for 2 consecutive months - 2 months and 5 days to be exact after having been on treatment for 14 months and culture negative since 2nd month of treatment. He was given an outcome of DEFAULTED. After 2 months, he came back for treatment ...

  • activity_icon

    Mamel Quelapio, MD replied to "Question about treatment outcome" in the MDR-TB Treatment & Prevention community.

    Dear Einar and Salmaan, Thanks for your responses. I agree that it can be quite challenging to strike the balance between the clinical and the programmatic ends. On Einar's options: In the recording and reporting system these options should be managed as follows: > Option (1): treatment outcome defaulted: Agree to put this for the first treatment but the question is really on what to do afterwards when he returns. > Option (2): treatment outcome ...

  • activity_icon

    Mamel Quelapio, MD replied to "External Quality Assessment of Tuberculosis Laboratories" in the MDR-TB Treatment & Prevention community.

    I would like to ask if this panel testing programme of GLI will include proficiency testing for line probe assay using HAIN. Some settings that are geared towards PMDT scale up like Vietnam have put this technique in place as the main diagnostic tool, so it is crucial to also put in place an external quality assurance system prior to the expansion. Many thanks.

  • activity_icon

    Mamel Quelapio, MD replied to "Tribute to Grace Egos" in the MDR-TB Treatment & Prevention community.

    Dear Paul and Massoud, On behalf of Grace's family and friends, thank you so much for starting this tribute. To Max Meis who faithfully cared for her during her hospital stay, and updated us every step of the way, our deepest thanks. To her friends who have expressed their love and care from Grace one way or another and expressed sympathy, thank you. We are overwhelmed by all your support. The loss and sadness is ...

More »

Recent Recommendations

  • None at this time.

Joined

August 28, 2008

Contributions

4

Recommendations

0